{"id":17,"date":"2024-08-22T17:07:00","date_gmt":"2024-08-22T17:07:00","guid":{"rendered":"http:\/\/b6d.c53.mytemp.website\/home\/?page_id=17"},"modified":"2026-06-11T17:11:05","modified_gmt":"2026-06-11T14:11:05","slug":"about-us","status":"publish","type":"page","link":"https:\/\/potentcells.com\/home\/about-us\/","title":{"rendered":"About Us"},"content":{"rendered":"

Cell & Gene Therapy Consultancy<\/h1>

For Academic-to-Seed Translation<\/h1>
<\/span>\"\"

Our Beliefs<\/h2>\n\n

We believe stem cell therapy is the answer to so many disorders, therefore, should be available to all<\/p>\n\n

We believe stem cell therapy is the answer to so many disorders, therefore, should be available to all<\/p><\/div>\n\n

You are a researcher, an investor, or an executive? If so, POTENTCELLS services are a good fit for you<\/p><\/div>\n\n

POTENTCELLS offer Stem Cell Therapy consultation and capacity building services that are customized to your project. Whether you are just starting to develop a process, or are gearing up for GMP production, we can help you achieve your goals<\/p><\/div><\/div><\/div><\/div>

<\/div>
<\/div>\n\n

Mission<\/h2>\n\n

To be a globally recognized and nationally integrated leader in advancing cellular therapies<\/p><\/div>\n\n

<\/div><\/div>\n\n

Vision<\/h2>\n\n

To enable investigators to deliver innovative cellular therapeutics through consultations, access to know-how, and sharing of expertise<\/p><\/div><\/div>

<\/div>

Our Story<\/h2>\n\n

Many of the brilliant innovators that I met over the years share three concerns, regulatory, technical, and commercial. These three areas are constantly changing just as the CGT field is constantly evolving. 86% of academic CGT discoveries never reach clinical development, not because the science fails, but because the operational translation between academia and industry is broken. University technology transfer offices (TTOs) are overwhelmed, and other consultancies have a different focus. Investors see promising science wrapped in an incomplete, uninventable package. Therefore, I established POTENTCELLS to fill that gap; from our base in Saudi Arabia by serving academic labs globally.<\/p>\n\n

We are the only consultancy built exclusively to close the academic\u2011to\u2011seed gap in cell and gene therapy (CGT). Our services cover\u00a0CAR\u2011T, gene editing, and other advanced therapy medicinal products.<\/p>\n\n

Naseem A. Almezel, CEO<\/strong><\/p>\n\n

What we do differently<\/h2>\n\n